Exelixis | EXEL - PE Price to Earnings


Exelixis reported $16.06 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
Agios Pharmaceuticals USD 2.88 0.36 Jun/2025
Amgen USD 9.49 3.02 Sep/2025
AstraZeneca USD 21.49 1.46 Sep/2025
Bayer EUR 5.93 0.68 Sep/2025
BioMarin Pharmaceutical USD 19.45 4.32 Sep/2025
Bristol-Myers Squibb USD 8.24 9.03 Sep/2025
Eisai JPY 26.16 4.7 Sep/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Exelixis USD 16.06 4.35 Sep/2025
Genmab DKK 12.75 0.62 Sep/2025
Glaxosmithkline GBP 11.93 6.46 Sep/2025
Incyte USD 17.63 2.86 Sep/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
Merck USD 8.84 0.26 Sep/2025
Moderna USD 27.22 14.51 Jun/2023
Neurocrine Biosciences USD 33.27 9.34 Sep/2025
Novartis USD 15.74 0.15 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
Sanofi EUR 15.75 1.53 Dec/2025
Takeda JPY 235.05 184.95 Dec/2025
Xencor USD 29.92 3.22 Sep/2022